{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:51:03Z","timestamp":1794664263712,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Natural Sciences Foundations of China","award":["No: 82504122"],"award-info":[{"award-number":["No: 82504122"]}]},{"name":"The Natural Sciences Foundations of Hunan Province","award":["No: 2024JJ6592"],"award-info":[{"award-number":["No: 2024JJ6592"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-026-01842-3","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T10:04:33Z","timestamp":1787047473000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Expression of LDHA, Pan-Kla Level and H3K18la associates with clinical progression of laryngeal squamous cell carcinoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Yangbingyu","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaolong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songqing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5338-543X","authenticated-orcid":false,"given":"Yuting","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"issue":"1","key":"1842_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1056\/NEJMra1715715","volume":"382","author":"LQM Chow","year":"2020","unstructured":"Chow LQM. Head and neck cancer. N Engl J Med. 2020;382(1):60\u201372.","journal-title":"N Engl J Med"},{"issue":"1","key":"1842_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6(1):92.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"1842_CR3","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1842_CR4","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1186\/s12885-021-08814-4","volume":"21","author":"QW Zhang","year":"2021","unstructured":"Zhang QW, Wang JY, Qiao XF, Li TL, Li X. Variations in disease burden of laryngeal cancer attributable to alcohol use and smoking in 204 countries or territories, 1990\u20132019. BMC Cancer. 2021;21(1):1082.","journal-title":"BMC Cancer"},{"issue":"95","key":"1842_CR5","doi-asserted-by":"publisher","first-page":"eadi4191","DOI":"10.1126\/sciimmunol.adi4191","volume":"9","author":"MP Plebanek","year":"2024","unstructured":"Plebanek MP, Xue Y, Nguyen YV, DeVito NC, Wang X, Holtzhausen A, et al. A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression. Sci Immunol. 2024;9(95):eadi4191.","journal-title":"Sci Immunol"},{"issue":"1","key":"1842_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s43556-025-00275-6","volume":"6","author":"X Peng","year":"2025","unstructured":"Peng X, Du J. Histone and non-histone lactylation: molecular mechanisms, biological functions, diseases, and therapeutic targets. Mol Biomed. 2025;6(1):38.","journal-title":"Mol Biomed"},{"issue":"11","key":"1842_CR7","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1002\/cac2.70054","volume":"45","author":"X Hou","year":"2025","unstructured":"Hou X, Hong Z, Zeng H, Zhang C, Zhang P, Ma D, et al. Lactylation in cancer biology: unlocking new avenues for research and therapy. Cancer Commun (Lond). 2025;45(11):1367\u2013406.","journal-title":"Cancer Commun (Lond)"},{"issue":"3","key":"1842_CR8","doi-asserted-by":"publisher","first-page":"e1614","DOI":"10.1002\/ctm2.1614","volume":"14","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Song H, Li M, Lu P. Histone lactylation bridges metabolic reprogramming and epigenetic rewiring in driving carcinogenesis: Oncometabolite fuels oncogenic transcription. Clin Transl Med. 2024;14(3):e1614.","journal-title":"Clin Transl Med"},{"issue":"7779","key":"1842_CR9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575\u201380.","journal-title":"Nature"},{"issue":"21","key":"1842_CR10","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1158\/0008-5472.CAN-23-3513","volume":"84","author":"C Zhang","year":"2024","unstructured":"Zhang C, Zhou L, Zhang M, Du Y, Li C, Ren H, et al. H3K18 lactylation potentiates immune escape of non-small cell lung cancer. Cancer Res. 2024;84(21):3589\u2013601.","journal-title":"Cancer Res"},{"key":"1842_CR11","doi-asserted-by":"publisher","first-page":"218158","DOI":"10.1016\/j.canlet.2025.218158","volume":"638","author":"A Shen","year":"2026","unstructured":"Shen A, Zheng S, Tang X, Yao Y, Yin E, Sun N, et al. Integrated multi-omics analyses identified the H3K18la-based spatiotemporal characteristics and risk-stratified treatment strategy in lung adenocarcinoma. Cancer Lett. 2026;638:218158.","journal-title":"Cancer Lett"},{"issue":"5","key":"1842_CR12","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.7150\/ijbs.91492","volume":"20","author":"X Yu","year":"2024","unstructured":"Yu X, Yang J, Xu J, Pan H, Wang W, Yu X, et al. Histone lactylation: from tumor lactate metabolism to epigenetic regulation. Int J Biol Sci. 2024;20(5):1833\u201354.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"1842_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12943-024-02008-9","volume":"23","author":"F Li","year":"2024","unstructured":"Li F, Si W, Xia L, Yin D, Wei T, Tao M, et al. Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma. Mol Cancer. 2024;23(1):90.","journal-title":"Mol Cancer"},{"issue":"2","key":"1842_CR14","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1002\/mco2.218","volume":"4","author":"S Nong","year":"2023","unstructured":"Nong S, Han X, Xiang Y, Qian Y, Wei Y, Zhang T, et al. Metabolic reprogramming in cancer: mechanisms and therapeutics. MedComm (2020). 2023;4(2):e218.","journal-title":"MedComm (2020)"},{"key":"1842_CR15","doi-asserted-by":"publisher","first-page":"216425","DOI":"10.1016\/j.canlet.2023.216425","volume":"577","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Guo Y, Ran M, Shan W, Granchi C, Giovannetti E, et al. Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing. Cancer Lett. 2023;577:216425.","journal-title":"Cancer Lett"},{"key":"1842_CR16","doi-asserted-by":"publisher","first-page":"100976","DOI":"10.1016\/j.drup.2023.100976","volume":"69","author":"S Wang","year":"2023","unstructured":"Wang S, Zhou L, Ji N, Sun C, Sun L, Sun J, et al. Targeting ACYP1-mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression. Drug Resist Updat. 2023;69:100976.","journal-title":"Drug Resist Updat"},{"issue":"12","key":"1842_CR17","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1038\/s42255-022-00708-4","volume":"4","author":"J Liu","year":"2022","unstructured":"Liu J, Zhang C, Zhang T, Chang CY, Wang J, Bazile L, et al. Metabolic enzyme LDHA activates Rac1 GTPase as a noncanonical mechanism to promote cancer. Nat Metab. 2022;4(12):1830\u201346.","journal-title":"Nat Metab"},{"issue":"6","key":"1842_CR18","doi-asserted-by":"publisher","first-page":"e3002666","DOI":"10.1371\/journal.pbio.3002666","volume":"22","author":"X Hou","year":"2024","unstructured":"Hou X, Ouyang J, Tang L, Wu P, Deng X, Yan Q, et al. KCNK1 promotes proliferation and metastasis of breast cancer cells by activating lactate dehydrogenase A (LDHA) and up-regulating H3K18 lactylation. PLoS Biol. 2024;22(6):e3002666.","journal-title":"PLoS Biol"},{"key":"1842_CR19","volume-title":"Head and neck tumours (WHO classification of tumours series","author":"WHO Classification of Tumours Editorial Board","year":"2022","unstructured":"WHO Classification of Tumours Editorial Board. Head and neck tumours (WHO classification of tumours series. Volume 9, 5th ed. Lyon: (France): International Agency for Research on Cancer; 2022.","edition":"5"},{"key":"1842_CR20","volume-title":"AJCC Cancer Staging Manual","year":"2017","unstructured":"Amin MB, Edge SB, Greene FL, et al. editors. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017.","edition":"8"},{"issue":"2","key":"1842_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41419-022-04565-7","volume":"13","author":"S Liu","year":"2022","unstructured":"Liu S, Wang W, Ning Y, Zheng H, Zhan Y, Wang H, et al. Exosome-mediated miR-7-5p delivery enhances the anticancer effect of Everolimus via blocking MNK\/eIF4E axis in non-small cell lung cancer. Cell Death Dis. 2022;13(2):129.","journal-title":"Cell Death Dis"},{"key":"1842_CR22","doi-asserted-by":"publisher","first-page":"114788","DOI":"10.1016\/j.intimp.2025.114788","volume":"158","author":"Y Du","year":"2025","unstructured":"Du Y, Xu Y, Wang W, Fan S. SSTR2 exhibits a positive correlation with PD-L1 and predicts poor prognosis in nasopharyngeal carcinoma. Int Immunopharmacol. 2025;158:114788.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"1842_CR23","doi-asserted-by":"publisher","first-page":"e2409416","DOI":"10.1002\/advs.202409416","volume":"12","author":"H Zheng","year":"2025","unstructured":"Zheng H, Tang Y, Zang H, Luo J, Zhou H, Zhan Y, et al. Itraconazole reversing acquired resistance to osimertinib in NSCLC by inhibiting the SHH\/DUSP13B\/p-STAT3 axis. Adv Sci (Weinh). 2025;12(7):e2409416.","journal-title":"Adv Sci (Weinh)"},{"key":"1842_CR24","doi-asserted-by":"crossref","unstructured":"Barsouk A, Aluru JS, Rawla P, Saginala K, Barsouk A. Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma. Med Sci (Basel). 2023;11(2):42.","DOI":"10.3390\/medsci11020042"},{"key":"1842_CR25","doi-asserted-by":"publisher","first-page":"102875","DOI":"10.1016\/j.arr.2025.102875","volume":"112","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Luo B, Sun X, Nagashima H, Wu Y, Liang G, et al. Non-histone lysine lactylation: emerging roles in tumor biology and therapeutic implications. Ageing Res Rev. 2025;112:102875.","journal-title":"Ageing Res Rev"},{"key":"1842_CR26","doi-asserted-by":"publisher","first-page":"1661697","DOI":"10.3389\/fmolb.2025.1661697","volume":"12","author":"J Jia","year":"2025","unstructured":"Jia J, Liu N, Zhu X, Chen M. Insights into recent findings and therapeutic potential of nonhistone lactylation in cancer. Front Mol Biosci. 2025;12:1661697.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"1842_CR27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41392-024-01918-w","volume":"9","author":"W Yao","year":"2024","unstructured":"Yao W, Hu X, Wang X. Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases. Signal Transduct Target Ther. 2024;9(1):232.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"1842_CR28","first-page":"546","volume":"130","author":"G Yao","year":"2024","unstructured":"Yao G, Yang Z. Glypican-3 knockdown inhibits the cell growth, stemness, and glycolysis development of hepatocellular carcinoma cells under hypoxic microenvironment through lactylation. Arch Physiol Biochem. 2024;130(5):546\u201354.","journal-title":"Arch Physiol Biochem"},{"key":"1842_CR29","doi-asserted-by":"publisher","first-page":"111760","DOI":"10.1016\/j.cbi.2025.111760","volume":"421","author":"M Li","year":"2025","unstructured":"Li M, Zhu T, Jiang F, Zhang W, Gao Y, Shen M, et al. Ginsenoside Rk1 suppresses the epithelial-mesenchymal transition of hepatic stellate cells via PFKFB2-mediated aerobic glycolysis. Chem Biol Interact. 2025;421:111760.","journal-title":"Chem Biol Interact"},{"key":"1842_CR30","doi-asserted-by":"crossref","unstructured":"Chen Q, Yuan H, Bronze MS, Li M. Targeting lactylation and the STAT3\/CCL2 axis to overcome immunotherapy resistance in pancreatic ductal adenocarcinoma. J Clin Invest. 2025;135(7).","DOI":"10.1172\/JCI191422"},{"issue":"1","key":"1842_CR31","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/15548627.2023.2249762","volume":"20","author":"W Li","year":"2024","unstructured":"Li W, Zhou C, Yu L, Hou Z, Liu H, Kong L, et al. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy. 2024;20(1):114\u201330.","journal-title":"Autophagy"},{"issue":"7","key":"1842_CR32","first-page":"1","volume":"14","author":"KKL Wong","year":"2021","unstructured":"Wong KKL, Verheyen EM. Metabolic reprogramming in cancer: mechanistic insights from Drosophila. Dis Model Mech. 2021;14(7):1\u201317.","journal-title":"Dis Model Mech"},{"key":"1842_CR33","doi-asserted-by":"publisher","first-page":"155874","DOI":"10.1016\/j.phymed.2024.155874","volume":"133","author":"Z Shi","year":"2024","unstructured":"Shi Z, Zeng H, Zhao B, Zeng C, Zhang F, Liu Z, et al. Sulforaphane reverses the enhanced NSCLC metastasis by regulating the miR-7-5p\/c-Myc\/LDHA axis in the acidic tumor microenvironment. Phytomedicine. 2024;133:155874.","journal-title":"Phytomedicine"},{"issue":"1","key":"1842_CR34","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12935-023-03162-8","volume":"23","author":"H Yang","year":"2023","unstructured":"Yang H, Yang S, He J, Li W, Zhang A, Li N, et al. Glucose transporter 3 (GLUT3) promotes lactylation modifications by regulating lactate dehydrogenase A (LDHA) in gastric cancer. Cancer Cell Int. 2023;23(1):303.","journal-title":"Cancer Cell Int"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-026-01842-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-026-01842-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-026-01842-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:24:27Z","timestamp":1787901867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13000-026-01842-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1842"],"URL":"https:\/\/doi.org\/10.1186\/s13000-026-01842-3","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"6 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethical Review Committee of Xiangya Second Hospital of Central South University approved the study protocols (Scientific and Research Ethics Committee, No. LYEC2025-K0145). All samples were collected with the consent of the patients or their families, and the experiments were conducted in accordance with all applicable regulations and guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"59"}}